WATSON 395 50 0 .5 (Naloxone Hydrochloride and Pentazocine Hydrochloride 0.5 mg / 50 mg)

Pill with imprint WATSON 395 50 0 .5 is Green, Elliptical / Oval and has been identified as Naloxone Hydrochloride and Pentazocine Hydrochloride 0.5 mg / 50 mg. It is supplied by Watson Pharmaceuticals.

Naloxone/pentazocine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Naloxone/pentazocine 0.5 mg / 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 395 50 0 .5

Naloxone Hydrochloride and Pentazocine Hydrochloride

Imprint:

WATSON 395 50 0 .5

Strength:

0.5 mg / 50 mg

Color:

Green

Size:

2.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Narcotic analgesic combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

4 - Some potential for abuse

Labeler / Supplier:

Watson Pharmaceuticals

Inactive Ingredients:

silicon dioxide
calcium phosphate dibasic anhydrous
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
66267-0487	Nucare Pharmaceuticals Inc. (repackager)
63874-0220	Altura Pharmaceuticals Inc. (repackager)
43063-0142	PDRX Pharmaceuticals Inc. (repackager)
35356-0176	Lake Erie Medical and Surgical Supply (repackager)

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer